Shares of Extendicare Inc. (OTCMKTS:EXETF – Get Free Report) traded down 2.3% during mid-day trading on Monday . The company traded as low as $9.68 and last traded at $9.68. 1,112 shares were traded during trading, a decline of 78% from the average session volume of 5,141 shares. The stock had previously closed at $9.91.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on EXETF. BMO Capital Markets reissued a “market perform” rating on shares of Extendicare in a report on Monday, May 12th. Royal Bank Of Canada reissued a “sector perform” rating on shares of Extendicare in a report on Tuesday, May 20th.
Read Our Latest Stock Report on Extendicare
Extendicare Trading Down 2.3%
Extendicare Increases Dividend
The business also recently declared a dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.031 per share. This represents a dividend yield of 3.64%. This is an increase from Extendicare’s previous dividend of $0.03. The ex-dividend date is Monday, June 30th. Extendicare’s dividend payout ratio (DPR) is presently -185.01%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
See Also
- Five stocks we like better than Extendicare
- The 3 Best Fintech Stocks to Buy Now
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- How to Short Nasdaq: An Easy-to-Follow Guide
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- Growth Stocks: What They Are, Examples and How to Invest
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.